On the other hand, among the prooncogenes, miR-26a-5p acts as an oncogenic microRNA in non-small-cell lung cancer by targeting FAF1 and might function as a possible therapeutic target [24]. Here, FAF1 is linked to non-small cell lung carcinoma.